🇨🇦 anti-infective therapy sitafloxacin in Canada

anti-infective therapy sitafloxacin (anti-infective therapy sitafloxacin) regulatory status in Canada.

Marketing authorisation

anti-infective therapy sitafloxacin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is anti-infective therapy sitafloxacin approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for anti-infective therapy sitafloxacin in Canada?

Shanghai Pulmonary Hospital, Shanghai, China is the originator. The local marketing authorisation holder may differ — check the official source linked above.